Spire Wealth Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-494
Closed -$1.28K 2485
2023
Q2
$1.28K Hold
494
﹤0.01% 2268
2023
Q1
$1.82K Hold
494
﹤0.01% 2282
2022
Q4
$1K Hold
494
﹤0.01% 2278
2022
Q3
$2K Hold
494
﹤0.01% 2017
2022
Q2
$3K Hold
494
﹤0.01% 2310
2022
Q1
$7K Sell
494
-250
-34% -$3.35K ﹤0.01% 2172
2021
Q4
$12K Buy
+744
New +$17.9K ﹤0.01% 2329
2021
Q2
Sell
-726
Closed -$38K 3038
2021
Q1
$38K Buy
+726
New +$38K ﹤0.01% 1869

Other funds holding DMTK

Spire Wealth Management's DMTK Position: Q3 2023 in Review

Spire Wealth Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2023, closing a stake of 494 shares — an estimated $1.28K sold.

Spire Wealth Management first reported a position in DMTK in Q1 2021 and held it in 8 quarters. The position peaked at $38K in Q1 2021. 78 funds tracked by Wall St. Rank hold DMTK as of Q3 2023.

  • Spire Wealth Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Spire Wealth Management sold 494 DermTech, Inc. Common Stock shares in Q3 2023, an estimated $1.28K.
  • Spire Wealth Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Spire Wealth Management's DermTech, Inc. Common Stock position peaked at $38K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.